Eintrag weiter verarbeiten
Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
Gespeichert in:
Zeitschriftentitel: | British Journal of Haematology |
---|---|
Personen und Körperschaften: | , , , , , , , , , , |
In: | British Journal of Haematology, 159, 2012, 1, S. 82-87 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Wiley
|
Schlagwörter: |
author_facet |
Jaglowski, Samantha M. Ruppert, Amy S. Heerema, Nyla A. Bingman, Anissa Flynn, Joseph M. Grever, Michael R. Jones, Jeffrey A. Elder, Patrick Devine, Steven M. Byrd, John C. Andritsos, Leslie A. Jaglowski, Samantha M. Ruppert, Amy S. Heerema, Nyla A. Bingman, Anissa Flynn, Joseph M. Grever, Michael R. Jones, Jeffrey A. Elder, Patrick Devine, Steven M. Byrd, John C. Andritsos, Leslie A. |
---|---|
author |
Jaglowski, Samantha M. Ruppert, Amy S. Heerema, Nyla A. Bingman, Anissa Flynn, Joseph M. Grever, Michael R. Jones, Jeffrey A. Elder, Patrick Devine, Steven M. Byrd, John C. Andritsos, Leslie A. |
spellingShingle |
Jaglowski, Samantha M. Ruppert, Amy S. Heerema, Nyla A. Bingman, Anissa Flynn, Joseph M. Grever, Michael R. Jones, Jeffrey A. Elder, Patrick Devine, Steven M. Byrd, John C. Andritsos, Leslie A. British Journal of Haematology Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia Hematology |
author_sort |
jaglowski, samantha m. |
spelling |
Jaglowski, Samantha M. Ruppert, Amy S. Heerema, Nyla A. Bingman, Anissa Flynn, Joseph M. Grever, Michael R. Jones, Jeffrey A. Elder, Patrick Devine, Steven M. Byrd, John C. Andritsos, Leslie A. 0007-1048 1365-2141 Wiley Hematology http://dx.doi.org/10.1111/j.1365-2141.2012.09239.x <jats:title>Summary</jats:title><jats:p>Complex karyotype (<jats:styled-content style="fixed-case">CK</jats:styled-content>) on metaphase cytogenetics discriminates poor outcome in chronic lymphocytic leukaemia (<jats:styled-content style="fixed-case">CLL</jats:styled-content>) patients undergoing salvage treatment; we hypothesized that it might provide prognostic information for patients undergoing allogeneic stem cell transplant. Fifty‐one <jats:styled-content style="fixed-case">CLL</jats:styled-content> patients were analysed following transplant; 18‐month overall survival (<jats:styled-content style="fixed-case">OS</jats:styled-content>), event‐free survival (<jats:styled-content style="fixed-case">EFS</jats:styled-content>) and cumulative incidence of progression estimates were 35%, 14% and 63%, respectively, in patients with <jats:styled-content style="fixed-case">CK</jats:styled-content> (<jats:italic>n</jats:italic> = 19) versus 83%, 68% and 29% in patients without (<jats:italic>n</jats:italic> = 32) (<jats:italic>P </jats:italic>≤ 0·0001, <jats:italic>P </jats:italic>≤ 0·0001, and <jats:italic>P</jats:italic> = 0·02). In patients with high‐risk interphase cytogenetics, <jats:styled-content style="fixed-case">CK</jats:styled-content> remained predictive of worse <jats:styled-content style="fixed-case">OS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·02) and <jats:styled-content style="fixed-case">EFS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·009). These findings support further evaluation of metaphase karyotype in transplant risk assessment.</jats:p> Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia British Journal of Haematology |
doi_str_mv |
10.1111/j.1365-2141.2012.09239.x |
facet_avail |
Online Free |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjE0MS4yMDEyLjA5MjM5Lng |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjE0MS4yMDEyLjA5MjM5Lng |
institution |
DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 |
imprint |
Wiley, 2012 |
imprint_str_mv |
Wiley, 2012 |
issn |
0007-1048 1365-2141 |
issn_str_mv |
0007-1048 1365-2141 |
language |
English |
mega_collection |
Wiley (CrossRef) |
match_str |
jaglowski2012complexkaryotypepredictsforinferioroutcomesfollowingreducedintensityconditioningallogeneictransplantforchroniclymphocyticleukaemia |
publishDateSort |
2012 |
publisher |
Wiley |
recordtype |
ai |
record_format |
ai |
series |
British Journal of Haematology |
source_id |
49 |
title |
Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
title_unstemmed |
Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
title_full |
Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
title_fullStr |
Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
title_full_unstemmed |
Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
title_short |
Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
title_sort |
complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
topic |
Hematology |
url |
http://dx.doi.org/10.1111/j.1365-2141.2012.09239.x |
publishDate |
2012 |
physical |
82-87 |
description |
<jats:title>Summary</jats:title><jats:p>Complex karyotype (<jats:styled-content style="fixed-case">CK</jats:styled-content>) on metaphase cytogenetics discriminates poor outcome in chronic lymphocytic leukaemia (<jats:styled-content style="fixed-case">CLL</jats:styled-content>) patients undergoing salvage treatment; we hypothesized that it might provide prognostic information for patients undergoing allogeneic stem cell transplant. Fifty‐one <jats:styled-content style="fixed-case">CLL</jats:styled-content> patients were analysed following transplant; 18‐month overall survival (<jats:styled-content style="fixed-case">OS</jats:styled-content>), event‐free survival (<jats:styled-content style="fixed-case">EFS</jats:styled-content>) and cumulative incidence of progression estimates were 35%, 14% and 63%, respectively, in patients with <jats:styled-content style="fixed-case">CK</jats:styled-content> (<jats:italic>n</jats:italic> = 19) versus 83%, 68% and 29% in patients without (<jats:italic>n</jats:italic> = 32) (<jats:italic>P </jats:italic>≤ 0·0001, <jats:italic>P </jats:italic>≤ 0·0001, and <jats:italic>P</jats:italic> = 0·02). In patients with high‐risk interphase cytogenetics, <jats:styled-content style="fixed-case">CK</jats:styled-content> remained predictive of worse <jats:styled-content style="fixed-case">OS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·02) and <jats:styled-content style="fixed-case">EFS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·009). These findings support further evaluation of metaphase karyotype in transplant risk assessment.</jats:p> |
container_issue |
1 |
container_start_page |
82 |
container_title |
British Journal of Haematology |
container_volume |
159 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792341500955197440 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T16:20:54.78Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Complex+karyotype+predicts+for+inferior+outcomes+following+reduced%E2%80%90intensity+conditioning+allogeneic+transplant+for+chronic+lymphocytic+leukaemia&rft.date=2012-10-01&genre=article&issn=1365-2141&volume=159&issue=1&spage=82&epage=87&pages=82-87&jtitle=British+Journal+of+Haematology&atitle=Complex+karyotype+predicts+for+inferior+outcomes+following+reduced%E2%80%90intensity+conditioning+allogeneic+transplant+for+chronic+lymphocytic+leukaemia&aulast=Andritsos&aufirst=Leslie+A.&rft_id=info%3Adoi%2F10.1111%2Fj.1365-2141.2012.09239.x&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792341500955197440 |
author | Jaglowski, Samantha M., Ruppert, Amy S., Heerema, Nyla A., Bingman, Anissa, Flynn, Joseph M., Grever, Michael R., Jones, Jeffrey A., Elder, Patrick, Devine, Steven M., Byrd, John C., Andritsos, Leslie A. |
author_facet | Jaglowski, Samantha M., Ruppert, Amy S., Heerema, Nyla A., Bingman, Anissa, Flynn, Joseph M., Grever, Michael R., Jones, Jeffrey A., Elder, Patrick, Devine, Steven M., Byrd, John C., Andritsos, Leslie A., Jaglowski, Samantha M., Ruppert, Amy S., Heerema, Nyla A., Bingman, Anissa, Flynn, Joseph M., Grever, Michael R., Jones, Jeffrey A., Elder, Patrick, Devine, Steven M., Byrd, John C., Andritsos, Leslie A. |
author_sort | jaglowski, samantha m. |
container_issue | 1 |
container_start_page | 82 |
container_title | British Journal of Haematology |
container_volume | 159 |
description | <jats:title>Summary</jats:title><jats:p>Complex karyotype (<jats:styled-content style="fixed-case">CK</jats:styled-content>) on metaphase cytogenetics discriminates poor outcome in chronic lymphocytic leukaemia (<jats:styled-content style="fixed-case">CLL</jats:styled-content>) patients undergoing salvage treatment; we hypothesized that it might provide prognostic information for patients undergoing allogeneic stem cell transplant. Fifty‐one <jats:styled-content style="fixed-case">CLL</jats:styled-content> patients were analysed following transplant; 18‐month overall survival (<jats:styled-content style="fixed-case">OS</jats:styled-content>), event‐free survival (<jats:styled-content style="fixed-case">EFS</jats:styled-content>) and cumulative incidence of progression estimates were 35%, 14% and 63%, respectively, in patients with <jats:styled-content style="fixed-case">CK</jats:styled-content> (<jats:italic>n</jats:italic> = 19) versus 83%, 68% and 29% in patients without (<jats:italic>n</jats:italic> = 32) (<jats:italic>P </jats:italic>≤ 0·0001, <jats:italic>P </jats:italic>≤ 0·0001, and <jats:italic>P</jats:italic> = 0·02). In patients with high‐risk interphase cytogenetics, <jats:styled-content style="fixed-case">CK</jats:styled-content> remained predictive of worse <jats:styled-content style="fixed-case">OS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·02) and <jats:styled-content style="fixed-case">EFS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·009). These findings support further evaluation of metaphase karyotype in transplant risk assessment.</jats:p> |
doi_str_mv | 10.1111/j.1365-2141.2012.09239.x |
facet_avail | Online, Free |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjE0MS4yMDEyLjA5MjM5Lng |
imprint | Wiley, 2012 |
imprint_str_mv | Wiley, 2012 |
institution | DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275 |
issn | 0007-1048, 1365-2141 |
issn_str_mv | 0007-1048, 1365-2141 |
language | English |
last_indexed | 2024-03-01T16:20:54.78Z |
match_str | jaglowski2012complexkaryotypepredictsforinferioroutcomesfollowingreducedintensityconditioningallogeneictransplantforchroniclymphocyticleukaemia |
mega_collection | Wiley (CrossRef) |
physical | 82-87 |
publishDate | 2012 |
publishDateSort | 2012 |
publisher | Wiley |
record_format | ai |
recordtype | ai |
series | British Journal of Haematology |
source_id | 49 |
spelling | Jaglowski, Samantha M. Ruppert, Amy S. Heerema, Nyla A. Bingman, Anissa Flynn, Joseph M. Grever, Michael R. Jones, Jeffrey A. Elder, Patrick Devine, Steven M. Byrd, John C. Andritsos, Leslie A. 0007-1048 1365-2141 Wiley Hematology http://dx.doi.org/10.1111/j.1365-2141.2012.09239.x <jats:title>Summary</jats:title><jats:p>Complex karyotype (<jats:styled-content style="fixed-case">CK</jats:styled-content>) on metaphase cytogenetics discriminates poor outcome in chronic lymphocytic leukaemia (<jats:styled-content style="fixed-case">CLL</jats:styled-content>) patients undergoing salvage treatment; we hypothesized that it might provide prognostic information for patients undergoing allogeneic stem cell transplant. Fifty‐one <jats:styled-content style="fixed-case">CLL</jats:styled-content> patients were analysed following transplant; 18‐month overall survival (<jats:styled-content style="fixed-case">OS</jats:styled-content>), event‐free survival (<jats:styled-content style="fixed-case">EFS</jats:styled-content>) and cumulative incidence of progression estimates were 35%, 14% and 63%, respectively, in patients with <jats:styled-content style="fixed-case">CK</jats:styled-content> (<jats:italic>n</jats:italic> = 19) versus 83%, 68% and 29% in patients without (<jats:italic>n</jats:italic> = 32) (<jats:italic>P </jats:italic>≤ 0·0001, <jats:italic>P </jats:italic>≤ 0·0001, and <jats:italic>P</jats:italic> = 0·02). In patients with high‐risk interphase cytogenetics, <jats:styled-content style="fixed-case">CK</jats:styled-content> remained predictive of worse <jats:styled-content style="fixed-case">OS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·02) and <jats:styled-content style="fixed-case">EFS</jats:styled-content> (<jats:italic>P</jats:italic> = 0·009). These findings support further evaluation of metaphase karyotype in transplant risk assessment.</jats:p> Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia British Journal of Haematology |
spellingShingle | Jaglowski, Samantha M., Ruppert, Amy S., Heerema, Nyla A., Bingman, Anissa, Flynn, Joseph M., Grever, Michael R., Jones, Jeffrey A., Elder, Patrick, Devine, Steven M., Byrd, John C., Andritsos, Leslie A., British Journal of Haematology, Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia, Hematology |
title | Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
title_full | Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
title_fullStr | Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
title_full_unstemmed | Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
title_short | Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
title_sort | complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
title_unstemmed | Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia |
topic | Hematology |
url | http://dx.doi.org/10.1111/j.1365-2141.2012.09239.x |